Carolyn O Connor
Family Medicine · Prosser, WANPI 1962425322
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $791 and has fallen 94.5% since, to $43 in 2025. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$473
- Teva Pharmaceuticals USA, Inc.$214
- AstraZeneca$205
- AbbVie$199
- GSK$180
- Novo Nordisk$121
- plus $670 from 18 others
What the payments were for
- Food & beverage$2,04499%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 31 | $473 |
| Teva Pharmaceuticals USA, Inc. | 11 | $214 |
| AstraZeneca | 14 | $205 |
| AbbVie | 11 | $199 |
| GSK | 9 | $180 |
| Novo Nordisk | 8 | $121 |
| Amgen | 5 | $88 |
| Boehringer Ingelheim | 4 | $82 |
| Lilly USA, LLC | 4 | $64 |
| Sanofi Pasteur Inc. | 3 | $49 |
| Bayer | 3 | $48 |
| Inspire Medical Systems, Inc. | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Novartis | 2 | $38 |
| Eisai Inc. | 2 | $37 |
| Merck | 2 | $33 |
| Pfizer | 2 | $32 |
| Johnson & Johnson | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$2,061 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Prosser
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
- Kent WalkerSumner$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.